The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection tests.
Guthrie KA, Anderson GL, Bell-Brown A, Cook LS, Doescher MP, Etzioni RB, Feng Z, Henderson LM, Herman J, Honda SA, James AS, Kaltman R, Kooperberg C, Krist AH, Lee CB, Lee JK, LeeVan E, Liao JC, Minasian LM, Moore KN, Nana-Sinkam P, Natale KE, Neslund-Dudas C, Ngo-Metzger Q, Ong MJC, Oshiro CES, Park Y, Patriotis C, Pinsky P, Prorok PC, Reuland DS, Ritzwoller DP, Rubinstein WS, Sakoda LC, Sayles J, Schenk JM, Shofer S, Simoff M, Toriola AT, White L, Wion ES, Wood M, Ramsey SD.
Guthrie KA, et al. Among authors: ritzwoller dp.
Contemp Clin Trials. 2026 Oct;169:108418. doi: 10.1016/j.cct.2026.108418. Epub 2026 Aug 9.
Contemp Clin Trials. 2026.
PMID: 42571808
Free PMC article.